Abstract
One of the strategies employed in immunotherapy for cancer is to use of ex vivo-generated dendritic cells (DC) pulsed with tumor antigens. Several approaches have been used to obtain and load tumor antigens in DC. One such technique is to use whole tumor cell lysate from one or more tumor cell lines of the tumor type to be treated. The advantage of applying this method is that it provides a large spectrum of tumor antigens. However, some considerations must be taken into account to obtain a lysate with appropriate biological activity, such as cell line harvest and the method to lyse the cells. In this chapter, we describe the steps to obtain whole tumor cell lysates from human tumor cell lines by repetitive freeze–thaw cycles in sufficient amount and quality to pulse DC.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Palucka K, Banchereau J (2012) Cancer immunotherapy via dendritic cells. Nat Rev Cancer 12:265–277
Novellino L et al (2005) A listing of human tumor antigens recognized by T cells: March 2004 update. Cancer Immunol Immunother 54:187–207
Chiang CL et al (2010) Whole tumor antigen vaccines. Semin Immunol 22:132–143
Ribas A et al (2010) Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma. J Transl Med 8:89
Prins RM et al (2011) Gene expression profile correlates with t-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clin Cancer Res 17:1603–1615
Herzog GI et al (2011) Quality of tumor lysates used for pulsing dendritic cells is influenced by the method used to harvest adherent tumor cells. BMC Res Notes 4:153
Schuler G et al (1995) Production and properties of large numbers of dendritic cells from human blood. In: Banchereau J, Schmitt D (eds) Dendritic cells in fundamental and clinical immunology. Springer, New York, pp 43–52
Mazzolini G et al (2005) Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas. J Clin Oncol 23:999–1010
Acknowledgement
This work was supported by grants from Austral University, Agencia Nacional de Promoción Científica y Tecnológica, Argentina.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Alaniz, L., Rizzo, M.M., Mazzolini, G. (2014). Pulsing Dendritic Cells with Whole Tumor Cell Lysates. In: Lawman, M., Lawman, P. (eds) Cancer Vaccines. Methods in Molecular Biology, vol 1139. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0345-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0345-0_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0344-3
Online ISBN: 978-1-4939-0345-0
eBook Packages: Springer Protocols